we should expect great variability in zooxanthellae density. Hence, bleaching events in corals within such lagoons may be frequent and part of the expected cycle of variability. Ser. 57, 173 (1989). 8. The data were collected from a lagoon near a small coastal village, Trou aux Biches, in the northwest of the island of Mauritius (latitude 20°S). The lagoonal area is about 4.1 ϫ 10 6 m 2 with an average depth of 2.5 m. There is a high degree of eutrophication in the lagoon with only 20% live coral cover (80 to 90% Acropora, and a few occurrences of Pocillopora and Porites), algal proliferation (50% Padina, 10% Sargassum, 5% Turbinaria, 5% Valonia, 5% Galaxaura, and 25% other), and a considerable degree of anthropogenic activity (swimming, boating, fishing, snorkeling, water-skiing). A colony was selected that lay in about 2 m of water, depending on the state of the tide. Coral samples were collected by breaking off one live coral tip (2 to 3 cm) from a randomly selected part of the same colony each week. 9. Dissolved oxygen and surface water temperature (at depths of 0.5 to 1.0 m) were taken in situ, and nitrate and phosphate concentrations were determined from water samples in the laboratory. Zooxanthellae were extracted from live coral tips according to Drew's technique (13) after decalcifying in 5% HCl. Aliquots of homogeneous extracts were placed on a hemocytometer (improved Neubauer counting chamber, depth 0.1 mm), and zooxanthellae cells were counted under an inverted microscope at ϫ400. The aluminum foil method of Marsh [ J. A. Marsh, Ecology 55, 255 (1970)] was used to calculate the surface area of the coral tip from which the zooxanthellae were extracted. Data on amounts of solar radiation and rainfall in the area were obtained from the Mauritius meteorological office.
where N t is the density of zooxanthellae at time t, a and b are constants, is a positive constant, and Z t has a normal distribution with a mean of 0 and a variance of 1, so that Z t is the term representing density-independent factors (random shocks). The time between successive points, t and t ϩ 1, is 1 week. A density-dependent model has a value for b significantly different from zero. The maximum likelihood estimates for the parameter values are a ϭ 0.15, b ϭ -0.10, and 2 ϭ 0.84; the probability of the null model being rejected is P ϭ 0.016 (as calculated by parametric bootstrapping). 13 16 . The sea surface temperature shows a seasonal fluctuation, with maximum temperatures in the summer period (December to April) just exceeding 30°C. The minimum temperature was 22.8°C (August 1993) and the maximum was 30.8°C (April 1994 Stem cell homing and repopulation are not well understood. The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 were found to be critical for murine bone marrow engraftment by human severe combined immunodeficient (SCID) repopulating stem cells. Treatment of human cells with antibodies to CXCR4 prevented engraftment. In vitro CXCR4-dependent migration to SDF-1 of CD34 ϩ CD38 Ϫ/low cells correlated with in vivo engraftment and stem cell function. Stem cell factor and interleukin-6 induced CXCR4 expression on CD34 ϩ cells, which potentiated migration to SDF-1 and engraftment in primary and secondary transplanted mice. Thus, up-regulation of CXCR4 expression may be useful for improving engraftment of repopulating stem cells in clinical transplantation.
Stem cells within the bone marrow microenvironment actively maintain continuous production of all mature blood cell lineages throughout life. These rare primitive cells are functionally defined by their ability to home to the bone marrow and to durably repopulate transplanted recipients with both myeloid and lymphoid cells (1, 2) . Several groups have established in vivo models for engrafting human stem cells (3) (4) (5) (6) (7) (8) . We developed a functional in vivo assay for primitive human SCID repopulating cells (SRCs) based on their ability to repopulate the bone marrow of intravenously transplanted SCID or nonobese diabetic SCID (NOD/SCID) mice with high levels of both myeloid and lymphoid cells (5, 6, 8) .
Chemokines are cytokines that are best known for their ability to selectively attract subsets of leukocytes to sites of inflammation (9) . The role that chemokines and their receptors play in homing and repopulation of human stem cells is not fully understood. The Hadassah University Hospital Jerusalem, 91120, Israel. 4 Kaplan Medical Center, Rehovot 76100, Israel. 5 Sourasky Medical Center, Tel Aviv 64239, Israel. 6 The Jackson Laboratory, Bar Harbor, ME 04609, USA. *To whom correspondence should be addressed. Email: litsvee@weizmann.weizmann.ac.il chemokine SDF-1 (10) binds to its receptor CXCR4, which is expressed on many cell types, including some CD34 ϩ
CD38
Ϫ cells (11, 12) . In vitro SDF-1 attracts certain CD34 ϩ CXCR4 ϩ cells, and in vivo it is produced by bone marrow stromal cells as well as by epithelial cells in many organs (11, 13, 14) . Mice that lack SDF-1 or do not express CXCR4 exhibit many defects, including the absence of both lymphoid and myeloid hematopoiesis in the fetal bone marrow (10, 15) . Overexpression of human CD4 and CXCR4 receptors on murine CD4
ϩ T cells led to enhanced homing of these cells to the murine bone marrow (16) .
To examine the in vivo role of SDF-1 and its receptor CXCR4 in migration and repopulation by human SRCs, we treated CD34 ϩ -enriched cord blood cells either with two different antibodies to CXCR4 or with control antibodies to CD34 (anti-CD34) before transplantation of NOD/SCID mice ( ϩ cord blood cells and readministered after 24 hours significantly reduced the level of engraftment (Fig. 1A, panel a) . The first 24 hours were critical to the engraftment process. Antibodies administered intraperitoneally 30 min after transplantation blocked engraftment (Fig. 1B) . Antibodies administered 24 hours later reduced engraftment less effectively and when administered 4 days after transplantation were completely ineffective ( Fig. 1B) 
(17).
The effects of SDF-1 desensitization and CXCR4 down-regulation on the ability of human CD34 ϩ cells to migrate and engraft NOD/SCID mice were further studied. SDF-1 and phorbol esters [phorbol 12-myristate 13-acetate (PMA)] cause internalization and down-regulation of CXCR4 surface expression on human CD4 ϩ T cells (18). Cord blood CD34 ϩ cells were incubated overnight with high doses of SDF-1. Cells were subsequently washed and tested for CXCR4 expression and migration to SDF-1 in a transwell assay. Treatment of CD34 ϩ cells with SDF-1 or PMA reduced CXCR4 cell surface expression (Fig. 1C, panel a) and abolished the migration of CD34 ϩ cells in response to SDF-1 (Fig. 1C, panel b) (19) . Prolonged treatment of CD34 ϩ cells with SDF-1 significantly blocked the engraftment of transplanted NOD/SCID mice (Fig. 1C, panel c) . Thus, SDF-1 probably affects SRC engraftment by mediating chemotaxis to the bone marrow, linking migration to SDF-1 in vitro to human stem cell function in vivo.
The migration potential of human CD34 ϩ cells from cord blood, bone marrow, or mo- bilized peripheral blood was tested in vitro in a transwell assay. Consistent with previous studies (13), 20 to 25% of cord blood and bone marrow CD34 ϩ cells migrated in response to a chemotactic gradient of SDF-1 in all donors tested ( Fig. 2A, panel a) . Migration of mobilized peripheral blood CD34 ϩ cells from multiple donors in response to SDF-1 was variable (between 8 to 60%), suggesting the involvement of SDF-1 in the mobilization process (Fig. 2A, panel a) . The migrating and nonmigrating CD34 ϩ cell populations did not differ in the incidence of progenitor cells, as determined by in vitro colony assays (Fig. 2A, panel b) ; however, the engraftment potential of the migrating and nonmigrating CD34 ϩ cells was different. Equal numbers of migrating (M) and nonmigrating (NM) CD34 ϩ cells were washed and transplanted into NOD/SCID or NOD/SCID ␤ 2 microglobulin knockout mice (20) . Whereas mice transplanted with nonmigrating cells were poorly engrafted, mice transplanted with migrating cells were significantly better engrafted ( Fig. 2A , panel c). The low concentrations of SDF-1 and the limited exposure time caused only a transient decrease of CXCR4 expression that did not prevent engraftment. These results are further evidence for the link between in vitro motility to SDF-1 and in vivo stem cell function.
Although only 20 to 25% of cord blood CD34 ϩ cells migrated toward SDF-1, this population contained a significantly higher percentage of primitive CD34 ϩ CD38 Ϫ cells than did nonmigrating cells ( Fig. 2A, panel  CB) . In CD34 ϩ cells from bone marrow, the proportion of immature CD34 ϩ CD38 Ϫ/low cells migrating to SDF-1 was larger than in cord blood ( Fig. 2A, panel BM) . Nevertheless, most cord blood CD34 ϩ CD38 Ϫ cells (60%) did not migrate to SDF-1, demonstrating that CD34 ϩ CD38 Ϫ cells are a heterogeneous population composed mostly of nonmigrating cells. Sorted CD34 ϩ CD38 Ϫ/low cord blood cells from different donors were evaluated for their ability to migrate toward a chemotactic gradient of SDF-1 in vitro on the basis of surface CXCR4 expression and for their content of SRCs in vivo. Only 26% (Ϯ7%) of the CD34 ϩ CD38 Ϫ/low cells migrated to a gradient of SDF-1 in the transwell assay. Transplantation of migrating CXCR4 ϩ cells into NOD/SCID mice resulted in high levels of multilineage engraftment (Fig. 2B) . This was reflected in the engraftment of primitive CD34 ϩ CD38 Ϫ cells (Fig. 2B , panel M) and lymphoid (Fig. 2B , panels Ma and Mb), and myeloid colony-forming cells. In contrast, little engraftment was observed with nonmigrating CXCR4 Ϫ/low cells (Fig. 2B, ϩ cells with SCF resulted in increased CXCR4 expression (Fig. 3A) , enhanced migration toward SDF-1 (Fig. 3B) , and enhanced engraftment potential dependent on the exposure time to SCF (Fig. 3C) . Engraftment potential was similarly increased when only half the cell number was injected after 40 hours of SCF treatment, compared with 16 hours of exposure or untreated cells transplanted at time 0 (Fig. 3D) . Thus, enhanced CXCR4-dependent migration to SDF-1 was accompanied by an increase in the SRC fraction. Incubation of SCF-stimulated, mobilized peripheral blood CD34
ϩ cells with anti-CXCR4 prevented engraftment (Fig. 3C) . Sorted CD34
CXCR4
Ϫ/low cord blood cells that did not migrate toward SDF-1 were either transplanted or treated with SCF for 48 hours. Whereas nontreated cells had low engraftment efficiency (Fig. 4A) 
CD38
Ϫ/low cord blood cells migrating toward SDF-1 were transplanted into NOD/SCID mice (3 ϫ 10 4 cells per mouse) (M). Nonmigrating cells were either injected directly (NM) or treated with SCF for 48 hours and then injected (ϩSCF). After 6 weeks engraftment levels were quantified as in Fig. 1C 
CXCR4
ϩ cells, properties that were similar to those of the original migrating fraction (M) (Fig. 4A) .
Self-renewal of stem cells can only be determined by their ability to also repopulate secondary transplanted recipients with high numbers of both myeloid and lymphoid cells. Consistent with previous studies, secondary transplanted mice that received untreated human cells showed little engraftment (Fig. 4B,  panel a) (22) . Human interleukin-6 (IL-6) synergizing with SCF induced high levels of CXCR4 expression on CD34
ϩ cord blood cells (Fig. 4C) . Incubation of bone marrow cells from primary transplanted mice with SCF and IL-6 for 48 hours resulted in upregulation of surface CXCR4 expression (Fig. 4B, panel c) and increased migration of human progenitor cells to SDF-1 in vitro (Fig. 4B, panel d) . Transplantation of similar numbers of human cells from the bone marrow of primary transplanted mice after treatment with these cytokines resulted in higher engraftment levels in secondary transplanted mice compared with mice transplanted with untreated cells (Fig. 4B, panel b versus panel  a) . Thus, by up-regulating surface CXCR4 expression on primitive cells, the population of self-renewing CD34 ϩ CD38 Ϫ/low SRC stem cells could be increased.
Our data provide evidence that CXCR4-dependent migration to SDF-1 is essential for human stem cell function in NOD/SCID mice. We characterized SRCs further as CD34 ϩ CD38 Ϫ/low CXCR4 ϩ stem cells and showed that CD34 ϩ
CD38
Ϫ/low CXCR4 Ϫ/low cells can be converted into functional CXCR4 ϩ stem cells by cytokine treatment. This suggests that migration to SDF-1 is associated with localization of stem cells in the bone marrow, permitting differentiating cells with reduced migration levels to exit into the blood circulation. In conclusion, our findings define human CD38 Ϫ/low CXCR4 ϩ cells as stem cells endowed with migration and repopulation potential and provide insights into human stem cell biology. 23. Human cells were obtained after informed consent according to procedures approved by the Weizmann Committee. In all experiments, samples of the same initial cell pool were compared. Differences in the results are due to the different CD34 ϩ cell sources (cord blood, bone marrow, and mobilized peripheral blood). CD34 ϩ enrichment, flow cytometry, and fluorescence-activated cell sorting (FACS) were performed as previously described (5, 6) . SDF-1 (125 ng/ml, R&D Systems) transmigration assays were done as previously described (13) . Human lymphoid and myeloid cells were immunostained with anti-CD45 (Immuno Quality Products, Groningen, Netherlands), anti-CD19, and anti-CD56 (Coulter). Natural killer cells differentiated into mature CD56 ϩ cells after incubation with human SCF (100 ng/ml) and human IL-15 (100 ng/ml, R&D Systems) for 10 days. NOD/SCID, and NOD/SCID ␤ 2 -microglobulin knockout (20) mice were bred and maintained under defined flora in intraventilated cages and transplanted by injection into the tail vein after sublethal (375R) irradiation according to established protocols (5, 6) approved by the Weizmann animal ethics committee. Southern (DNA) blot analysis with a human-specific ␣ satellite probe and human-specific progenitor assays were done as previously described (5, 6) . Percent engraftment always indicates the percent of either human DNA or of human CD45 cells in the mouse bone marrow. The levels of engraftment were dependent on the injected cell dose, the duration of the experiment, and the source of human CD34 ϩ cells. Cells were cultured either in serum-free media as previously described (6) Costimulation of both the CD3 and CD28 receptors is essential for T cell activation. Induction of adenosine 3Ј,5Ј-monophosphate (cAMP)-specific phosphodiesterase-7 (PDE7) was found to be a consequence of such costimulation. Increased PDE7 in T cells correlated with decreased cAMP, increased interleukin-2 expression, and increased proliferation. Selectively reducing PDE7 expression with a PDE7 antisense oligonucleotide inhibited T cell proliferation; inhibition was reversed by blocking the cAMP signaling pathways that operate through cAMP-dependent protein kinase (PKA). Thus, PDE7 induction and consequent suppression of PKA activity is required for T cell activation, and inhibition of PDE7 could be an approach to treating T cell-dependent disorders.
Activation of peripheral T cells in vivo by an antigen-presenting cell is a result of the engagement of both the T cell receptor-CD3 complex (TCR-CD3) and the CD28 costimulatory receptor. When both receptors are occupied by their appropriate ligands, T cells are stimulated to proliferate and produce interleukin-2 (IL-2), whereas occupation of the T cell receptor alone favors T cell anergy or apoptosis (1) . Occupation of the CD28 receptor alone appears to have no obvious effect on T cells; nevertheless, CD28 costimulation is required for full activation of CD4 T helper cells, if not all T cells (2) . Why is CD28 costimulation required for T cell activation? One possible reason has been suggested by
